TARO

Taro Pharmaceutical Industries Ltd.
TARO

Overview Fund Activity
Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

114 hedge funds and large institutions have $421M invested in Taro Pharmaceutical Industries Ltd. in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 16 closing their positions.

Holders
114
Holders Change
+5
Holders Change %
+4.59%
% of All Funds
2.61%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
21
Increased
32
Reduced
31
Closed
16
Calls
$29K
Puts
–
Net Calls
+$29K
Net Calls Change
-$52K

Top Buyers

1
GC
1
Globeflex Capital
California
$7.12M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$27.7M
3
Citadel Advisors
3
Citadel Advisors
Florida
$4.42M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$32.5M
5
Invesco
5
Invesco
Georgia
$18.8M

Top Sellers

1
MICM
1
Matthews International Capital Management
California
$0
2
FL
2
Fort LP
Maryland
$10.4M
3
Millennium Management
3
Millennium Management
New York
$460K
4
SCP
4
Seizert Capital Partners
Michigan
$0
5
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Canada Pension Plan Investment Board
26
Canada Pension Plan Investment Board
Ontario, Canada
$4.06M +$1.02M +10,377 +34%
Wellington Management Group
27
Wellington Management Group
Massachusetts
$3.97M -$1.16M -11,814 -23%
Man Group
28
Man Group
United Kingdom
$3.7M -$1.03M -10,445 -22%
Robeco Institutional Asset Management
29
Robeco Institutional Asset Management
Netherlands
$3.56M +$298K +3,030 +9%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.02M +$1.04M +10,567 +53%
Russell Investments Group
31
Russell Investments Group
United Kingdom
$2.43M +$85.6K +871 +4%
Boston Partners
32
Boston Partners
Massachusetts
$2.25M -$62.9K -640 -3%
Goldman Sachs
33
Goldman Sachs
New York
$2.18M -$555K -5,649 -20%
AG
34
Aperio Group
California
$2.15M +$259K +2,631 +14%
JPMorgan Chase & Co
35
JPMorgan Chase & Co
New York
$1.95M -$157K -1,596 -7%
OAM
36
Oxford Asset Management
United Kingdom
$1.74M -$398K -4,057 -19%
EF
37
Empirical Finance
Pennsylvania
$1.35M – – –
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.32M +$66.4K +675 +5%
Deutsche Bank
39
Deutsche Bank
Germany
$1.24M +$811K +8,257 +190%
SFM
40
Systematic Financial Management
New Jersey
$1.16M -$5.4K -55 -0.5%
Barclays
41
Barclays
United Kingdom
$1.15M +$397K +4,033 +52%
American Century Companies
42
American Century Companies
Missouri
$1.03M +$1.03M +10,495 New
Charles Schwab
43
Charles Schwab
California
$1.01M +$20.1K +204 +2%
HCM
44
Hudson Capital Management
New Jersey
$975K +$67.6K +687 +7%
AIM
45
Assured Investment Management
New York
$911K +$219K +2,230 +32%
BlackRock
46
BlackRock
New York
$743K +$328K +3,338 +79%
Creative Planning
47
Creative Planning
Kansas
$701K – – –
Marshall Wace
48
Marshall Wace
United Kingdom
$689K +$689K +7,007 New
SEI Investments
49
SEI Investments
Pennsylvania
$648K -$228K -2,325 -26%
HAM
50
Highstreet Asset Management
Ontario, Canada
$584K +$57.8K +588 +11%
1
2
3 4 5